Long-term infliximab treatment for Behçet's disease

Jpn J Ophthalmol. 2007 May-Jun;51(3):239-40. doi: 10.1007/s10384-006-0424-z. Epub 2007 Jun 7.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / therapeutic use*
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / therapeutic use*
  • Behcet Syndrome / drug therapy*
  • Behcet Syndrome / pathology
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Follow-Up Studies
  • Humans
  • Infliximab
  • Male
  • Retina / pathology
  • Retrospective Studies
  • Time Factors
  • Tumor Necrosis Factor-alpha
  • Visual Acuity
  • Vitreous Body / pathology

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Tumor Necrosis Factor-alpha
  • Infliximab